Pharsight

Aquestive patents expiration

1. Sympazan patents expiration

SYMPAZAN's oppositions filed in EPO
SYMPAZAN Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765167 AQUESTIVE Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Feb, 2024

(4 months from now)

US8603514 AQUESTIVE Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Apr, 2024

(6 months from now)

Drugs and Companies using CLOBAZAM ingredient

Market Authorisation Date: 01 November, 2018

Treatment: NA

Dosage: FILM;ORAL

More Information on Dosage

SYMPAZAN family patents

Family Patents

2. Zuplenz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8580830 AQUESTIVE Non-mucoadhesive film dosage forms
Nov, 2029

(6 years from now)

US9095577 AQUESTIVE Stabilized amine-containing actives in oral film compositions
Jul, 2030

(6 years from now)

Drugs and Companies using ONDANSETRON ingredient

Market Authorisation Date: 02 July, 2010

Treatment: NA

Dosage: FILM;ORAL

More Information on Dosage

ZUPLENZ family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic